Daily ideas

Supervielle, Banco Macro and Telecom Argentina disclosed in August 2026 that disinflation ended peso wage-bill erosion, so cost cuts now require cash severance.

Car carrier capacity is sold out and yard slots are gone until 2029, so Chinese exporters now sign two- to five-year freight contracts, not one-year deals.

Codan, Unusual Machines and Mobilicom told August 2026 earnings calls that drone demand is outrunning electronics supply, making Codan's 20% FY27 target conditional.

uniQure, ClearPoint and BioCardia disclosed the FDA no longer requires a sham-surgery control in rare CNS gene therapy, moving the gate to delivery hardware.

On their Q2 2026 calls HydrogenPro and Nel said they will no longer build whole electrolysers in house; HydrogenPro took a NOK 32m impairment on Tianjin.

Odfjell's contract share fell from 57% to 45% as Gulf cargo vanished, and dual-capable tankers stay in higher-paying product and crude trades.

Bavarian Nordic, SIGA, Emergent and Valneva told August 2026 calls that sovereign and multilateral budgets, not outbreak awards, now drive vaccine orders.

Australian listed property vehicles sold FY26 assets at 17-25% premiums to book while their units trade 25-32% below NTA, closing the equity-raising route.

Energy Vault, Fervo, Hyliion and APA Group say data center owners now buy their own generation, with each supplier delivering only one tranche.

Sunrise and Spark said on August 19 that every operator in their market raised monthly bills, with churn milder than past rounds and lasting one quarter.

Since the pattern day trader rule ended on 4 June 2026, Webull's options contracts rose 34% sequentially against 7% for equity notional, and Cboe measured it.

ZTO, FlashEX and ATRenew told Q2 2026 calls that below-cost price competition is now a violation; ZTO cut 2026 parcel volume growth to 6-10% from 10-13%.

Ülker Bisküvi says it cannot raise Turkish list prices with inflation: volume rose 1.3%, revenue fell 11.4%, domestic EBITDA margin slid to 12.7%.

NovaBridge says the FDA's first-line population for givastomig requires only CLDN18.2 positivity, with no staining cutoff, and sizes it at 105,000 patients.

Contact Energy, Mercury NZ and Alfen told August 2026 calls that build and installation capacity, not permits or demand, now sets power delivery.

VGP, WDP and Tritax Big Box told H1 2026 calls that permits and buildable land cap new European logistics supply; VGP's reletting uplift fell to 6% from 14%.

Argentina dropped the export-revenue test on bank dollar loans and capped each bank at 15% of its FX deposits, about $5.2bn, and Banco Macro now guides only its dollar book to grow.

Novonesis and Green Plains say ethanol demand growth now comes from blend mandates in Brazil, India and Indonesia, lifting per-liter enzyme volume.

Sisram, AbbVie and Evolus told investors injectable aesthetics is now priced by how long an effect lasts: Juvederm fell 6.6% while DAXXIFY holds RMB6,800.